Cargando…
Vemurafenib in the Treatment of Erdheim Chester Disease: A Systematic Review
Erdheim Chester disease (ECD) is a type of histiocytosis characterized by a variable clinical presentation. The treatment of ECD is complex and mainly unknown. We aim to conduct a literature review of the treatment of ECD and consolidate the knowledge about the most recent and updated treatment for...
Autores principales: | Aziz, Syed N, Proano, Lucia, Cruz, Claudio, Tenemaza, Maria Gabriela, Monteros, Gustavo, Hassen, Gashaw, Baskar, Aakash, Argudo, Jennifer M, Duenas, Jonathan B, Fabara, Stephanie P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9282605/ https://www.ncbi.nlm.nih.gov/pubmed/35844342 http://dx.doi.org/10.7759/cureus.25935 |
Ejemplares similares
-
Orbital and chorioretinal manifestations of Erdheim-Chester disease treated with vemurafenib
por: Huang, Laura C., et al.
Publicado: (2018) -
An effective treatment in Erdheim Chester disease: vemurafenib: a case report
por: Bozan, Ersin, et al.
Publicado: (2023) -
Excellent response of intramedullary Erdheim-Chester disease to vemurafenib: a case report
por: Tzoulis, Charalampos, et al.
Publicado: (2015) -
FDA Approval Summary: Vemurafenib for the Treatment of Patients with Erdheim‐Chester Disease with the BRAFV600 Mutation
por: Oneal, Patricia A., et al.
Publicado: (2018) -
Vemurafenib for BRAF V600‐mutant Erdheim–Chester disease presenting with bilateral orbital involvement
por: Wang, Xiaomeng, et al.
Publicado: (2023)